159 related articles for article (PubMed ID: 38092046)
1. Maternal serum concentrations of per- and polyfluoroalkyl substances and childhood acute lymphoblastic leukemia.
Jones RR; Madrigal JM; Troisi R; Surcel HM; Öhman H; Kivelä J; Kiviranta H; Rantakokko P; Koponen J; Medgyesi DN; McGlynn KA; Sampson J; Albert PS; Ward MH
J Natl Cancer Inst; 2024 May; 116(5):728-736. PubMed ID: 38092046
[TBL] [Abstract][Full Text] [Related]
2. Prediagnostic serum concentrations of per- and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity Cohort.
Madrigal JM; Troisi R; Surcel HM; Öhman H; Kivelä J; Kiviranta H; Rantakokko P; Koponen J; Medgyesi DN; Kitahara CM; McGlynn KA; Sampson J; Albert PS; Ward MH; Jones RR
Int J Cancer; 2024 Mar; 154(6):979-991. PubMed ID: 37902275
[TBL] [Abstract][Full Text] [Related]
3. Prenatal Maternal Serum Concentrations of Per- and Polyfluoroalkyl Substances in Association with Autism Spectrum Disorder and Intellectual Disability.
Lyall K; Yau VM; Hansen R; Kharrazi M; Yoshida CK; Calafat AM; Windham G; Croen LA
Environ Health Perspect; 2018 Jan; 126(1):017001. PubMed ID: 29298162
[TBL] [Abstract][Full Text] [Related]
4. Attention deficit/hyperactivity disorder and childhood autism in association with prenatal exposure to perfluoroalkyl substances: a nested case-control study in the Danish National Birth Cohort.
Liew Z; Ritz B; von Ehrenstein OS; Bech BH; Nohr EA; Fei C; Bossi R; Henriksen TB; Bonefeld-Jørgensen EC; Olsen J
Environ Health Perspect; 2015 Apr; 123(4):367-73. PubMed ID: 25616253
[TBL] [Abstract][Full Text] [Related]
5. Prenatal exposure to per- and polyfluoroalkyl substances and infant growth and adiposity: the Healthy Start Study.
Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Dabelea D
Environ Int; 2019 Oct; 131():104983. PubMed ID: 31284113
[TBL] [Abstract][Full Text] [Related]
6. Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Facial Features at 5 Years of Age: A Study from the Danish National Birth Cohort.
Luo J; Ramlau-Hansen CH; Kesmodel US; Xiao J; Vasiliou V; Deziel NC; Zhang Y; Olsen J; Liew Z
Environ Health Perspect; 2022 Jan; 130(1):17006. PubMed ID: 35080464
[TBL] [Abstract][Full Text] [Related]
7. Association between prenatal or early postnatal exposure to perfluoroalkyl substances and language development in 18 to 36-month-old children from the Odense Child Cohort.
Beck IH; Bilenberg N; Andersen HR; Trecca F; Bleses D; Jensen TK
Environ Health; 2023 May; 22(1):46. PubMed ID: 37254153
[TBL] [Abstract][Full Text] [Related]
8. Per- and polyfluoroalkyl substances (PFAS) and fetal growth: A nation-wide register-based study on PFAS in drinking water.
Säve-Söderbergh M; Gyllenhammar I; Schillemans T; Lindfeldt E; Vogs C; Donat-Vargas C; Halldin Ankarberg E; Glynn A; Ahrens L; Helte E; Åkesson A
Environ Int; 2024 May; 187():108727. PubMed ID: 38735074
[TBL] [Abstract][Full Text] [Related]
9. Maternal Plasma Perfluoroalkyl Substances and Miscarriage: A Nested Case-Control Study in the Danish National Birth Cohort.
Liew Z; Luo J; Nohr EA; Bech BH; Bossi R; Arah OA; Olsen J
Environ Health Perspect; 2020 Apr; 128(4):47007. PubMed ID: 32319790
[TBL] [Abstract][Full Text] [Related]
10. Modeled prenatal exposure to per- and polyfluoroalkyl substances in association with child autism spectrum disorder: A case-control study.
Shin HM; Bennett DH; Calafat AM; Tancredi D; Hertz-Picciotto I
Environ Res; 2020 Jul; 186():109514. PubMed ID: 32353786
[TBL] [Abstract][Full Text] [Related]
11. Exposure to per- and polyfluoroalkyl substances in early pregnancy and risk of cerebral palsy in children.
Vilhelmsson A; Rylander L; Jöud A; Lindh CH; Mattsson K; Liew Z; Guo P; Ritz B; Källén K; Thacher JD
Sci Total Environ; 2023 Nov; 899():165622. PubMed ID: 37474063
[TBL] [Abstract][Full Text] [Related]
12. PFAS (per- and polyfluoroalkyl substances) and asthma in young children: NHANES 2013-2014.
Jackson-Browne MS; Eliot M; Patti M; Spanier AJ; Braun JM
Int J Hyg Environ Health; 2020 Aug; 229():113565. PubMed ID: 32485600
[TBL] [Abstract][Full Text] [Related]
13. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.
Chen Q; Huang R; Hua L; Guo Y; Huang L; Zhao Y; Wang X; Zhang J
Environ Health; 2018 Jan; 17(1):8. PubMed ID: 29343261
[TBL] [Abstract][Full Text] [Related]
14. Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: The Hokkaido study on environment and children's health.
Ait Bamai Y; Goudarzi H; Araki A; Okada E; Kashino I; Miyashita C; Kishi R
Environ Int; 2020 Oct; 143():105979. PubMed ID: 32717646
[TBL] [Abstract][Full Text] [Related]
15. Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and associations with hypertensive disorders of pregnancy in the Atlanta African American Maternal-Child cohort.
Thompson M; Eatman JA; Dunlop AL; Barr DB; Kannan K; Corwin EJ; Ryan PB; Panuwet P; Yakimavets V; Taibl KR; Tan Y; Liang D; Eick SM
Chemosphere; 2024 Jun; 357():142052. PubMed ID: 38631500
[TBL] [Abstract][Full Text] [Related]
16. Prenatal exposures to per- and polyfluoroalkyl substances and epigenetic aging in umbilical cord blood: The Healthy Start study.
Niemiec SS; Kechris K; Pattee J; Yang IV; Adgate JL; Calafat AM; Dabelea D; Starling AP
Environ Res; 2023 Aug; 231(Pt 2):116215. PubMed ID: 37224946
[TBL] [Abstract][Full Text] [Related]
17. Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental Influences on Child Health Outcomes (ECHO) Program.
Padula AM; Ning X; Bakre S; Barrett ES; Bastain T; Bennett DH; Bloom MS; Breton CV; Dunlop AL; Eick SM; Ferrara A; Fleisch A; Geiger S; Goin DE; Kannan K; Karagas MR; Korrick S; Meeker JD; Morello-Frosch R; O'Connor TG; Oken E; Robinson M; Romano ME; Schantz SL; Schmidt RJ; Starling AP; Zhu Y; Hamra GB; Woodruff TJ;
Environ Health Perspect; 2023 Mar; 131(3):37006. PubMed ID: 36920051
[TBL] [Abstract][Full Text] [Related]
18. Early Life Exposures to Perfluoroalkyl Substances in Relation to Adipokine Hormone Levels at Birth and During Childhood.
Shelly C; Grandjean P; Oulhote Y; Plomgaard P; Frikke-Schmidt R; Nielsen F; Zmirou-Navier D; Weihe P; Valvi D
J Clin Endocrinol Metab; 2019 Nov; 104(11):5338-5348. PubMed ID: 31216000
[TBL] [Abstract][Full Text] [Related]
19. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
[TBL] [Abstract][Full Text] [Related]
20. Behavioral difficulties in 7-year old children in relation to developmental exposure to perfluorinated alkyl substances.
Oulhote Y; Steuerwald U; Debes F; Weihe P; Grandjean P
Environ Int; 2016 Dec; 97():237-245. PubMed ID: 27692925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
